Skip to content

XBI

State Street SPDR S&P Biotech ETF

$145.04−0.24 (−0.17%)Close Nov 18, 2026

Adjusted price

+26.47% total return, past year

Key statistics

Expense ratio
0.35%
52-week range
$113.83$169.55
All-time high close
$173.99 on Feb 8, 2021
From all-time high
−16.64%
Max drawdown
−63.89%
Volatility
30.60%
Sharpe ratio
0.51
Beta (5Y monthly)
0.86

Total

1M
+0.50%
YTD
+19.07%
1Y
+26.47%

Per year

3Y
+26.18%
5Y
+3.61%
10Y
+8.35%
20Y
+11.50%
Since 2006
+11.35%

Fund facts

As of Jun 30, 2026
Net assets
$10.7B
Holdings
161
Top 10 holdings
18.0%
Stocks
99.9%
Cash
5.9%

Sectors

Health Care
99.2%
Financials
0.5%
Other
0.2%

Top holdings

HoldingWeight (%)
State Street Global Advisors5.9
APGEApogee Therapeutics, Inc.1.5
MRNAModerna, Inc.1.4
TWSTTwist Bioscience Corporation1.4
ORKAOruka Therapeutics, Inc.1.4
KYMRKymera Therapeutics, Inc.1.4
VKTXViking Therapeutics, Inc.1.3
PRAXPraxis Precision Medicines, Inc.1.3
ERASErasca, Inc.1.3
RVMDRevolution Medicines, Inc.1.2